As of 2024-09-08, the EV/EBITDA ratio of Intercept Pharmaceuticals Inc (ICPT) is -22.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICPT's latest enterprise value is 915.51 mil USD. ICPT's TTM EBITDA according to its financial statements is -40.56 mil USD. Dividing these 2 quantities gives us the above ICPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 9.6x | 7.9x |
| Forward P/E multiples | 4.8x - 15.4x | 10.0x |
| Fair Price | (9.88) - (12.21) | (11.56) |
| Upside | -152.0% - -164.3% | -160.8% |
| Date | EV/EBITDA |